BC Platforms, Modirum, VEIL.AI and Productivity Leap introduce an AI-enabled reference architecture that automates EHDS2 data discovery, access and secure analysis.
Dr Jan Berger becomes Chair of the Board at BC Platforms, reinforcing our global strategy and leadership in Real-World Data and healthcare innovation.
BC Platforms and NTT Life Science Corporation form an exclusive collaboration to drive data-driven medicine and strengthen Real-World Data capabilities worldwide.
BC Platforms acquires Medexprim, expanding our ability to deliver secure access to Real-World clinical and imaging Data for global biopharma across Europe.
BC Platforms and NTT join forces to integrate and harmonize Japanese healthcare data, supporting data-driven medicine and nationwide personalized care.
BC Platforms strengthens its global offering with the acquisition of 4Pharma, combining CRO expertise with advanced Real-World Data technology.
BC Platforms powers data analysis for the HELIOS study in Singapore, advancing the nation’s precision medicine programme and enabling insights across major chronic diseases.
BC Platforms and partners win phase 2 of the Instand-NGS4P project, continuing work to deliver standardized NGS-based oncology workflows across leading European hospitals.
BC Platforms partners with HUS on ONCOVALUE, a Horizon Europe project creating an AI framework to turn clinical data into Real-World Evidence for cancer treatment decisions.
For press and media inquiries, contact our communications team at media@bcplatforms.com.
For partnerships, business opportunities, and all other inquiries, please fill out this form